JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 36 No. 3 476-483
© 1995 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glover, D. K.
Right arrow Articles by Beller, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glover, D. K.
Right arrow Articles by Beller, G. A.

Myocardial Technetium-99m-Teboroxime Uptake during Adenosine-Induced Hyperemia in Dogs with Either a Critical or Mild Coronary Stenosis: Comparison to Thallium-201 and Regional Blood Flow

David K. Glover, Mirta Ruiz, Elizabeth E. Bergmann, Juris P. Simanis, William H. Smith, Denny D. Watson and George A. Beller

Experimental Cardiology Laboratory, Division of Cardiology, Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, Virginia

Correspondence: For correspondence or reprints contact: David K. Glover, Experimental Cardiology Laboratory, Box 500, University of Virginia Health Sciences Center, Charlottesville, VA 22908.

ABSTRACT

Experimental studies have shown 99mTc-teboroxime to have a higher first-pass myocardial extraction, exceeding that of 201TI with nearly linear initial myocardial uptake over a wide range of coronary flows. The goal of this study was to quantitatively compare teboroxime with 201TI the assessment of a regional coronary flow imbalance when administered during adenosine vasodilation in dogs with either critical or mild LAD stenoses. Methods: Twenty-four anesthetized dogs with either critical (n= 10) or mild (n = 14) LAD stenoses were given an i.v. infusion of adenosine (300 µg/kg/min). When LCx flow was maximal, 201TI, teboroxime and microspheres were simultaneously injected and the dogs were killed either 2 or 4 min later. Regional 201TI, teboroxime activities and myocardial blood flow were determined by gamma well counting and ex vivo imaging of 99mTc-teboroxime activity in myocardial heart slices was performed. Results: In both the critical and mild stenosis groups, the LAD/LCx zone ratios in dogs killed 2 min after tracer injection for both 201TI (0.31 ± 0.07, 0.63 ± 0.05) and teboroxime (0.38 ± 0.09, 0.72 ± 0.04) significantly underestimated the microsphere flow ratio (0.18 ± 0.05, 0.43 ± 0.05) (p ≤ 0.01), but the degree of underestimation was greater for teboroxime compared with TI (p ≤ 0.05). Conclusion: In dogs with either critical or mild LAD stenoses, as early as 2 min after tracer injection, the 201TI activity ratio more accurately assessed the adenosine-induced regional flow heterogeneity than did teboroxime. These results highlight the importance of an ultra-fast imaging protocol when using teboroxime with pharmacologic stress.

Key Words: thallium-201 • teboroxime • adenosine • hyperemia • coronary stenosis




This article has been cited by other articles:


Home page
CirculationHome page
D. A. Calnon, M. Ruiz, G. Vanzetto, D. D. Watson, G. A. Beller, and D. K. Glover
Myocardial Uptake of 99mTc-N-NOET and 201Tl During Dobutamine Infusion : Comparison With Adenosine Stress
Circulation, October 12, 1999; 100(15): 1653 - 1659.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1995 by the Society of Nuclear Medicine.